the ProtecT Study Group (2019). Factors associated with trial recruitment, preferences, and treatments received were elucidated in a comprehensive cohort study. Journal of Clinical Epidemiology, 113, 200-213.

,

[1]  T. Peters,et al.  A prospective cohort and extended comprehensive-cohort design provided insights about the generalizability of a pragmatic trial: the ProtecT prostate cancer trial , 2017, Journal of clinical epidemiology.

[2]  T. Wilt,et al.  Follow‐up of Prostatectomy versus Observation for Early Prostate Cancer , 2017, The New England journal of medicine.

[3]  M. Cooperberg,et al.  Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years , 2017, JAMA.

[4]  Ronald C. Chen,et al.  Association Between Choice of Radical Prostatectomy, External Beam Radiotherapy, Brachytherapy, or Active Surveillance and Patient-Reported Quality of Life Among Men With Localized Prostate Cancer , 2017, JAMA.

[5]  David Gillatt,et al.  10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer. , 2017, The New England journal of medicine.

[6]  A. Agarwal,et al.  A systematic review of discontinued trials suggested that most reasons for recruitment failure were preventable. , 2016, Journal of clinical epidemiology.

[7]  J. Donovan,et al.  Conveying Equipoise during Recruitment for Clinical Trials: Qualitative Synthesis of Clinicians’ Practices across Six Randomised Controlled Trials , 2016, PLoS medicine.

[8]  U. Siebert,et al.  TREATMENT SWITCHING: STATISTICAL AND DECISION-MAKING CHALLENGES AND APPROACHES , 2016, International Journal of Technology Assessment in Health Care.

[9]  R. Saskin,et al.  Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. , 2016, European urology.

[10]  J. Donovan,et al.  Optimising recruitment and informed consent in randomised controlled trials: the development and implementation of the Quintet Recruitment Intervention (QRI) , 2016, Trials.

[11]  J. Johnston,et al.  A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results , 2015, Trials.

[12]  F. Hamdy,et al.  Training recruiters to randomized trials to facilitate recruitment and informed consent by exploring patients' treatment preferences , 2014, Trials.

[13]  F. Hamdy,et al.  The intellectual challenges and emotional consequences of equipoise contributed to the fragility of recruitment in six randomized controlled trials☆ , 2014, Journal of clinical epidemiology.

[14]  J. Donovan,et al.  Clear obstacles and hidden challenges: understanding recruiter perspectives in six pragmatic randomised controlled trials , 2014, Trials.

[15]  P. Sedgwick.  What is a patient preference trial? , 2013 .

[16]  C. Ramsay,et al.  Minimal access surgery compared with medical management for gastro-oesophageal reflux disease: five year follow-up of a randomised controlled trial (REFLUX) , 2013, BMJ : British Medical Journal.

[17]  F. Hamdy,et al.  Exploring treatment preferences facilitated recruitment to randomized controlled trials , 2011, Journal of clinical epidemiology.

[18]  B. Djulbegovic.  The paradox of equipoise: the principle that drives and limits therapeutic discoveries in clinical research. , 2009, Cancer control : journal of the Moffitt Cancer Center.

[19]  M Egger,et al.  The causes and effects of socio-demographic exclusions from clinical trials. , 2005, Health technology assessment.

[20]  P. Bower,et al.  Impact of participant and physician intervention preferences on randomized trials: a systematic review. , 2005, JAMA.

[21]  F. Song,et al.  Evaluating non-randomised intervention studies. , 2003, Health technology assessment.

[22]  T. Peters,et al.  SCORING THE SHORT FORM ICSmaleSF QUESTIONNAIRE , 2000 .

[23]  H M Sandler,et al.  Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. , 2000, Urology.

[24]  A. Garratt,et al.  The impact of using a partially randomised patient preference design when evaluating alternative managements for heavy menstrual bleeding , 1997, British journal of obstetrics and gynaecology.

[25]  P. Slovic.  The Construction of Preference , 1995 .

[26]  R. Henshaw,et al.  Comparison of medical abortion with surgical vacuum aspiration: women's preferences and acceptability of treatment. , 1993, BMJ.

[27]  B. Freedman.  Equipoise and the ethics of clinical research. , 1987, The New England journal of medicine.

[28]  Huston Gj,et al.  The Hospital Anxiety and Depression Scale. , 1987, The Journal of rheumatology.

[29]  T. Peters,et al.  Development of a complex intervention improved randomization and informed consent in a randomized controlled trial. , 2009, Journal of clinical epidemiology.

[30]  J. Donovan,et al.  ICIQ: A brief and robust measure for evaluating the symptoms and impact of urinary incontinence , 2004, Neurourology and urodynamics.